67 related articles for article (PubMed ID: 2609664)
1. [In vivo flow of autologous radioactively labeled low-density lipoproteins (LDL) in human blood vessels].
Virgolini I; Angelberger P; Lupattelli G; Pidlich J; Sinzinger H
Wien Klin Wochenschr; 1989 Dec; 101(23):798-805. PubMed ID: 2609664
[TBL] [Abstract][Full Text] [Related]
2. Imaging and kinetics studies with radiolabelled autologous low-density lipoproteins (LDL) in human atherosclerosis.
Sinzinger H; Angelberger P
Nucl Med Commun; 1988 Oct; 9(10):859-66. PubMed ID: 3211443
[TBL] [Abstract][Full Text] [Related]
3. Low density lipoprotein labelling characterizes experimentally induced atherosclerotic lesions in rabbits in vivo as to presence of foam cells and endothelial coverage.
Virgolini I; Angelberger P; O'Grady J; Sinzinger H
Eur J Nucl Med; 1991; 18(12):944-7. PubMed ID: 1778203
[TBL] [Abstract][Full Text] [Related]
4. Imaging of human atherosclerotic lesions using 123I-low-density lipoprotein.
Sinzinger H; Bergmann H; Kaliman J; Angelberger P
Eur J Nucl Med; 1986; 12(5-6):291-2. PubMed ID: 3780773
[TBL] [Abstract][Full Text] [Related]
5. Autologous low-density lipoprotein labelling allows characterization of human atherosclerotic lesions in vivo as to presence of foam cells and endothelial coverage.
Virgolini I; Rauscha F; Lupattelli G; Angelberger P; Ventura A; O'Grady J; Sinzinger H
Eur J Nucl Med; 1991; 18(12):948-51. PubMed ID: 1778204
[TBL] [Abstract][Full Text] [Related]
6. Evidence for lipid regression in humans in vivo performed by 123iodine-low-density lipoprotein scintiscanning.
Pirich C; Sinzinger H
Ann N Y Acad Sci; 1995 Jan; 748():613-21. PubMed ID: 7695216
[TBL] [Abstract][Full Text] [Related]
7. Technetium-99m low density lipoproteins: preparation and biodistribution.
Lees RS; Garabedian HD; Lees AM; Schumacher DJ; Miller A; Isaacsohn JL; Derksen A; Strauss HW
J Nucl Med; 1985 Sep; 26(9):1056-62. PubMed ID: 4032046
[TBL] [Abstract][Full Text] [Related]
8. Unusual imaging of varicose veins after radiolabeling of autologous low-density lipoproteins.
Rodrigues M; Granegger S; Kritz H; Sinzinger H
Rev Esp Med Nucl; 1998; 17(6):442-5. PubMed ID: 9873132
[TBL] [Abstract][Full Text] [Related]
9. Isradipine decreases the entry of radioiodine-labelled low-density lipoproteins into the arterial wall.
Pirich C; Fitscha P; Schmid P; Sinzinger H
Blood Press Suppl; 1994; 1():70-4. PubMed ID: 8205306
[TBL] [Abstract][Full Text] [Related]
10. Study of blood lipid content and occurrence of hyperlipoproteinemias in hypertensive patients of various age.
Tokar AV; Chayalo PP; Rudaya ES
Z Alternsforsch; 1985; 40(1):41-6. PubMed ID: 3976251
[TBL] [Abstract][Full Text] [Related]
11. Imaging human atherosclerosis with 99mTc-labeled low density lipoproteins.
Lees AM; Lees RS; Schoen FJ; Isaacsohn JL; Fischman AJ; McKusick KA; Strauss HW
Arteriosclerosis; 1988; 8(5):461-70. PubMed ID: 3190553
[TBL] [Abstract][Full Text] [Related]
12. In vivo quantification of cholesterol content in human carotid arteries by quantitative gamma-camera imaging after injection of autologous low density lipoproteins (LDL).
Virgolini I; O'Grady J; Lupattelli G; Rauscha F; Angelberger P; Ventura S; Sinzinger H
Int J Rad Appl Instrum B; 1992 Feb; 19(2):245-50. PubMed ID: 1601677
[TBL] [Abstract][Full Text] [Related]
13. The physical structure of low-density lipoprotein in hyperlipoproteinemias and atherosclerosis.
Bihari-Varga M; Gruber E; Tölgyesi F
Monogr Atheroscler; 1986; 14():173-8. PubMed ID: 3736559
[No Abstract] [Full Text] [Related]
14. [Hyperlipoproteinemia as the cause of increased plasma antiheparin activity in patients with arteriosclerosis].
Rółkowski R; Worowski K; Skrzydlewski Z; Głowiński S
Kardiol Pol; 1986; 29(3):204-8. PubMed ID: 3773409
[No Abstract] [Full Text] [Related]
15. Potential of 99mTc-LDLs labeled by two different methods for scintigraphic detection of experimental atherosclerosis in rabbits.
Atsma DE; Feitsma RI; Camps J; van't Hooft FM; van der Wall EE; Nieuwenhuizen W; Pauwels EK
Arterioscler Thromb; 1993 Jan; 13(1):78-83. PubMed ID: 8422342
[TBL] [Abstract][Full Text] [Related]
16. Increased low-density lipoproteins (LDL) negatively affect human platelet labelling.
Granegger S; Flores J; Widhalm K; Sinzinger H
Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(4):451-3. PubMed ID: 2465951
[No Abstract] [Full Text] [Related]
17. Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man.
Ylä-Herttuala S; Palinski W; Rosenfeld ME; Parthasarathy S; Carew TE; Butler S; Witztum JL; Steinberg D
J Clin Invest; 1989 Oct; 84(4):1086-95. PubMed ID: 2794046
[TBL] [Abstract][Full Text] [Related]
18. Imaging of human atherosclerotic lesions by 123-I-low-density lipoproteins (LDL).
Sinzinger H; Kaliman J; Widhalm K; Angelberger P; Höfer A; Bergmann H
Prog Clin Biol Res; 1988; 255():183-96. PubMed ID: 3340637
[No Abstract] [Full Text] [Related]
19. Comparison of plasma clearance of low density lipoprotein with beta-very low density lipoprotein or acetoacetylated low density lipoprotein in cholesterol-fed rabbits.
Asai K; Hayashi T; Funaki C; Kuzuya M; Naito M; Kuzuya F
Biochem Int; 1991 Jan; 23(2):327-34. PubMed ID: 1859435
[TBL] [Abstract][Full Text] [Related]
20. [Visualization of carotid and femoral atherosclerotic lesions using autologous lipoprotein reinjection containing apo-B marked with 131I: preliminary data].
Lupattelli G; Fiacconi M; Orecchini G; Fedeli L; Siepi D; Pistola L; Deleide G; Palumbo R
Medicina (Firenze); 1989; 9(4):398-400. PubMed ID: 2634224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
